|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| C07K 14/495 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3638243 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18816685.4 |
| Date of filing the European patent application | 2018-06-13 | |
| (97) | Date of publication of the European application | 2020-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2024-08-07 |
| (46) | Date of publication of the claims translation | 2024-11-11 |
| (86) | Number | PCT/US2018/037213 |
| Date | 2018-06-13 |
| (87) | Number | WO 2018/231905 |
| Date | 2018-12-20 |
| (30) | Number | Date | Country code |
| 201762519725 P | 2017-06-14 | US | |
| 201862679210 P | 2018-06-01 | US |
| (72) |
LAADEM, Abderrahmane , US
GALE, Robert , US
|
| (73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Su mieloproliferacine neoplazma susijusios mielofibrozės ir anemijos gydymo būdai |
| METHODS FOR TREATING MYELOPROLIFERATIVE NEOPLASM-ASSOCIATED MYELOFIBROSIS AND ANEMIA |
| Payment date | Validity (years) | Amount | |
| 2025-05-05 | 8 | 185.00 EUR |
| 2026-06-13 |